Confined placental mosaicism for trisomy 14 and maternal uniparental disomy in association with elevated second trimester maternal serum human chorionic gonadotrophin and third trimester fetal growth restriction

Citation
Dr. Towner et al., Confined placental mosaicism for trisomy 14 and maternal uniparental disomy in association with elevated second trimester maternal serum human chorionic gonadotrophin and third trimester fetal growth restriction, PRENAT DIAG, 21(5), 2001, pp. 395-398
Citations number
20
Categorie Soggetti
Reproductive Medicine","Medical Research Diagnosis & Treatment
Journal title
PRENATAL DIAGNOSIS
ISSN journal
01973851 → ACNP
Volume
21
Issue
5
Year of publication
2001
Pages
395 - 398
Database
ISI
SICI code
0197-3851(200105)21:5<395:CPMFT1>2.0.ZU;2-5
Abstract
A case of confined placental mosaicism (CPM) and maternal uniparental isodi somy 14 identified after placental karyotype revealed trisomy 14 in a newbo rn with intrauterine growth restriction (IUGR) and minor dysmorphic feature s is reported. During the second trimester of the pregnancy, multiple marke r screening revealed an increased risk for Down syndrome of >1 in 10. The m aternal serum human chorionic gonadotrophin (MShCG) was markedly elevated a t 4.19 MoM. Amniocentesis revealed a normal 46,XX karyotype. Fetal growth r estriction has been associated with elevated MShCG and placental aneuploidy with CPM for chromosomes 2, 7, 9 and 16. The present case of CPM for chrom osome 14 was also associated with fetal growth restriction and elevated sec ond trimester MShCG, suggesting a common link. Further studies need to be d one to determine if indeed elevation of second trimester MShCG is associate d with increased risk of CPM. The present case again demonstrates the need to perform placental karyotype in unexplained fetal growth restriction. Cop yright (C) 2001 John Wiley & Sons, Ltd.